A review of the evidence for and against increased mortality in hypothyroidism

Nature Reviews Endocrinology

Volumn 8, Issue 7, 2012, Pages 417-424

  Thvilum, Marianne ^a   Brandt, Frans ^a   Brix, Thomas H ^a   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; LEVOTHYROXINE; LITHIUM; THYROID HORMONE; THYROTROPIN;

CARDIOVASCULAR DISEASE; COMORBIDITY; DEMOGRAPHY; DISEASE CLASSIFICATION; DRUG COMPETITION; FOLLOW UP; HUMAN; HYPOTHYROIDISM; LIFESPAN; MORTALITY; OVERT HYPOTHYROIDISM; PRIORITY JOURNAL; REVIEW; SUBCLINICAL HYPOTHYROIDISM; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

HUMANS; HYPOTHYROIDISM; THYROXINE;

EID: 84862500039     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.29     Document Type: Review

References (93)

1. Carle, A. et al. Epidemiology of subtypes of hypothyroidism in Denmark. Eur. J. Endocrinol. 154, 21-28 (2006).
2. Vanderpump, M. P. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 43, 55-68 (1995).
3. Canaris, G. J., Manowitz, N. R., Mayor, G. & Ridgway, E. C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526-534 (2000).
4. Brix, T. H., Kyvik, K. O. & Hegedüs, L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab. 85, 536-539 (2000).
5. Laurberg, P. et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract. Res. Clin. Endocrinol. Metab. 24, 13-27 (2010).
6. Jensen, E. et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin. Chem. Lab. Med. 42, 824-832 (2004).
7. Erem, C. Thyroid disorders and hypercoagulability. Semin. Thromb. Hemost. 37, 17-26 (2011).
8. Pearce, E. N. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr. Cardiol. Rep. 6, 451-456 (2004).
9. Goldman, M. B., Monson, R. R. & Maloof, F. Cancer mortality in women with thyroid disease. Cancer Res. 50, 2283-2289 (1990).
10. Maldonado, L. S., Murata, G. H., Hershman, J. M. & Braunstein, G. D. Do thyroid function tests independently predict survival in the critically ill? Thyroid 2, 119-123 (1992).
11. Imaizumi, M. et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 89, 3365-3370 (2004).
12. Sgarbi, J. A., Matsumura, L. K., Kasamatsu, T. S., Ferreira, S. R. & Maciel, R. M. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur. J. Endocrinol. 162, 569-577 (2010).
13. McQuade, C. et al. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: A PreCIS database study. Thyroid 21, 837-843 (2011).
14. Flynn, R. W., MacDonald, T. M., Jung, R. T., Morris, A. D. & Leese, G. P. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J. Clin. Endocrinol. Metab. 91, 2159-2164 (2006).
15. Nyirenda, M. J. et al. Thyroid disease and increased cardiovascular risk. Thyroid 15, 718-724 (2005).
16. Boekholdt, S. M. et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin. Endocrinol. (Oxf.) 72, 404-410 (2010).
17. Razvi, S., Weaver, J. U., Vanderpump, M. P. & Pearce, S. H. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J. Clin. Endocrinol. Metab. 95, 1734-1740 (2010).
18. Rodondi, N. et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch. Intern. Med. 165, 2460-2466 (2005).
19. Haentjens, P., van Meerhaeghe, A., Poppe, K. & Velkeniers, B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur. J. Endocrinol. 159, 329-341 (2008).
20. Rodondi, N. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365-1374 (2010).
21. Singh, S. et al. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int. J. Cardiol. 125, 41-48 (2008).
22. Ochs, N. et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832-845 (2008).
23. Völzke, H., Schwahn, C., Wallaschofski, H. & Dörr, M. Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J. Clin. Endocrinol. Metab. 92, 2421-2429 (2007).
24. Buffenstein, R. & Pinto, M. Endocrine function in naturally long-living small mammals. Mol. Cell Endocrinol. 299, 101-111 (2009).
25. Atzmon, G., Barzilai, N., Hollowell, J. G., Surks, M. I. & Gabriely, I. Extreme longevity is associated with increased serum thyrotropin. J. Clin. Endocrinol. Metab. 94, 1251-1254 (2009).
26. Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P. & Franklyn, J. A. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358, 861-865 (2001).
27. Gussekloo, J. et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 292, 2591-2599 (2004).
28. Walsh, J. P. et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch. Intern. Med. 165, 2467-2472 (2005).
29. Cappola, A. R. et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033-1041 (2006).
30. Iervasi, G. et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch. Intern. Med. 167, 1526-1532 (2007).
31. Asvold, B. O., Bjøro, T., Nilsen, T. I., Gunnell, D. & Vatten, L. J. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch. Intern. Med. 168, 855-860 (2008).
32. Radácsi, A. et al. Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. Endocrine 21, 133-136 (2003).
33. Bauer, D. C., Rodondi, N., Stone, K. L. & Hillier, T. A. Thyroid hormone use, hyperthyroidism and mortality in older women. Am. J. Med. 120, 343-349 (2007).
34. Chubb, S. A., Davis, W. A., Inman, Z. & Davis, T. M. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin. Endocrinol. (Oxf.) 62, 480-486 (2005).
35. Schultz, M. et al. Cardiovascular events in thyroid disease: a population based, prospective study. Horm. Metab Res. 43, 653-659 (2011).
36. de Jongh, R. T. et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur. J. Endocrinol. 165, 545-554 (2011).
37. Petersen, K., Bengtsson, C., Lapidus, L., Lindstedt, G. & Nystrom, E. Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch. Intern. Med. 150, 2077-2081 (1990).
38. Alevizaki, M., Synetou, M., Xynos, K., Alevizaki, C. C. & Vemmos, K. N. Hypothyroidism as a protective factor in acute stroke patients. Clin. Endocrinol. (Oxf.) 65, 369-372 (2006).
39. Vanderpump, M. P. et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6, 155-160 (1996).
40. Slag, M. F. et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245, 43-45 (1981).
41. Iglesias, P. et al. Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin. Endocrinol. (Oxf.) 70, 961-967 (2009).
42. Franklyn, J. A. Thyroid disease and its treatment: short- and long-term consequences. J. R. Coll. Physicians Lond. 33, 564-567 (1999).
43. Osman, F., Gammage, M. D. & Franklyn, J. A. Thyroid disease and its treatment: short-term and long-term cardiovascular consequences. Curr. Opin. Pharmacol. 1, 626-631 (2001).
44. van den Beld, A. W., Visser, T. J., Feelders, R. A., Grobbee, D. E. & Lamberts, S. W. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J. Clin. Endocrinol. Metab. 90, 6403-6409 (2005).
45. Lloyd-Jones, D. et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 121, 948-954 (2010).
46. Klein, I. & Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501-509 (2001).
47. Biondi, B. & Cooper, D. S. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76-131 (2008).
48. Biondi, B. & Klein, I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24, 1-13 (2004).
49. Kahaly, G. J. & Dillmann, W. H. Thyroid hormone action in the heart. Endocr. Rev. 26, 704-728 (2005).
50. Kahaly, G. J. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10, 665-679 (2000).
51. Luboshitzky, R., Aviv, A., Herer, P. & Lavie, L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12, 421-425 (2002).
52. Nagasaki, T. et al. Increased pulse wave velocity in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 91, 154-158 (2006).
53. Biondi, B. et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 84, 2064-2067 (1999).
54. Vitale, G. et al. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J. Clin. Endocrinol. Metab. 87, 4350-4355 (2002).
55. Lekakis, J. et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7, 411-414 (1997).
56. Vescovi, P. P. et al. The spectrum of coagulation abnormalities in thyroid disorders. Semin. Thromb. Hemost. 37, 7-10 (2011).
57. Cappola, A. R. & Ladenson, P. W. Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438-2444 (2003).
58. Lindeman, R. D. et al. Subclinical hypothyroidism in a biethnic, urban community. J. Am. Geriatr. Soc. 47, 703-709 (1999).
59. Holm, L. E., Blomgren, H. & Lowhagen, T. Cancer risks in patients with chronic lymphocytic thyroiditis. N. Engl. J. Med. 312, 601-604 (1985).
60. Acton, R. T., Go, R. C. & Roseman, J. M. Genetics and cardiovascular disease. Ethn. Dis. 14, S2-8-16 (2004).
61. Bak, S., Gaist, D., Sindrup, S. H., Skytthe, A. & Christensen, K. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke 33, 769-774 (2002).
62. Herskind, A. M. et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum. Genet. 97, 319-323 (1996).
63. Rice, F., Harold, G. T. & Thapar, A. Assessing the effects of age, sex and shared environment on the genetic aetiology of depression in childhood and adolescence. J. Child Psychol. Psychiatry 43, 1039-1051 (2002).
64. Madden, P. A., Pedersen, N. L., Kaprio, J., Koskenvuo, M. J. & Martin, N. G. The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. Twin Res. 7, 82-97 (2004).
65. Umpierrez, G. E. et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care 26, 1181-1185 (2003).
66. Gulseren, S. et al. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch. Med. Res. 37, 133-139 (2006).
67. Guimarães, J. M., de Souza, L. C., Baima, J. & Sichieri, R. Depression symptoms and hypothyroidism in a population-based study of middle-aged Brazilian women. J. Affect. Disord. 117, 120-123 (2009).
68. Laursen, T. M., Munk-Olsen, T. & Gasse, C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS ONE 6, e24597 (2011).
69. Bauer, M., Heinz, A. & Whybrow, P. C. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatry 7, 140-156 (2002).
70. Brix, T. H., Hansen, P. S., Kyvik, K. O. & Hegedüs, L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch. Intern. Med. 160, 661-666 (2000).
71. Belin, R. M., Astor, B. C., Powe, N. R. & Ladenson, P. W. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 89, 6077-6086 (2004).
72. Davidsen, M., Kjoller, M. & Helweg-Larsen, K. The Danish National Cohort Study (DANCOS). Scand. J. Public Health 39, 131-135 (2011).
73. Madsen, M., Andersen, A. M., Christensen, K., Andersen, P. K. & Osler, M. Does educational status impact adult mortality in Denmark? A twin approach. Am. J. Epidemiol. 172, 225-234 (2010).
74. Andersen, K. K. & Olsen, T. S. Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke. Stroke 38, 259-263 (2007).
75. Woloshin, S., Schwartz, L. M. & Welch, H. G. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J. Natl Cancer Inst. 100, 845-853 (2008).
76. Hansen, P. S., Brix, T. H., Sorensen, T. I., Kyvik, K. O. & Hegedüs, L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89, 1181-1187 (2004).
77. Brabant, G. et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J. Clin. Endocrinol. Metab. 70, 403-409 (1990).
78. Andersen, S., Pedersen, K. M., Bruun, N. H. & Laurberg, P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87, 1068-1072 (2002).
79. Karmisholt, J., Andersen, S. & Laurberg, P. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur. J. Endocrinol. 164, 317-323 (2011).
80. Karmisholt, J., Andersen, S. & Laurberg, P. Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. Thyroid 18, 303-308 (2008).
81. Metso, S., Auvinen, A., Salmi, J., Huhtala, H. & Jaatinen, P. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin Endocrinol (Oxf.) 68, 450-457 (2008).
82. Warner, M. H. & Beckett, G. J. Mechanisms behind the non-thyroidal illness syndrome: an update. J. Endocrinol. 205, 1-13 (2010).
83. Hamblin, P. S. et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J. Clin. Endocrinol. Metab. 62, 717-722 (1986).
84. Karadag, F., Ozcan, H., Karul, A. B., Yilmaz, M. & Cildag, O. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease. Respir. Med. 101, 1439-1446 (2007).
85. Haugen, B. R. Drugs that suppress TSH or cause central hypothyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 23, 793-800 (2009).
86. Eskes, S. A. & Wiersinga, W. M. Amiodarone and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 23, 735-751 (2009).
87. Stockigt, J. R. & Lim, C. F. Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract. Res. Clin. Endocrinol. Metab. 23, 753-767 (2009).
88. Barbesino, G. Drugs affecting thyroid function. Thyroid 20, 763-770 (2010).
89. Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 40, 373-383 (1987).
90. Toft, A. D. Thyroxine therapy. N. Engl. J. Med. 331, 174-180 (1994).
91. McGue, M., Osler, M. & Christensen, K. Causal inference and observational research: the utility of twins. Perspect. Psychol. Sci. 5, 546-556 (2010).
92. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 7, 177-188 (1986).
93. Higgins, J., Thompson, S., Deeks, J. & Altman, D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J. Health Serv. Res. Policy 7, 51-61 (2002).